Cargando…
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey
A recent explosion in the amount of cardiovascular risk and incipient, undetected subclinical cardiovascular pathology has swept across the globe. Nearly 70% of adult Americans are overweight or obese; the prevalence of visceral obesity stands at 53% and continues to rise. At any one time, 55% of th...
Autor principal: | Kones, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140289/ https://www.ncbi.nlm.nih.gov/pubmed/21792295 http://dx.doi.org/10.2147/DDDT.S14934 |
Ejemplares similares
-
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective
por: Kones, Richard
Publicado: (2010) -
The Evolving View of Coronary Artery Calcium: A Personalized Shared Decision-Making Tool in Primary Prevention
por: Dzaye, Omar, et al.
Publicado: (2019) -
Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
por: Firouzi, Ata, et al.
Publicado: (2018) -
The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome
por: Sexton, Travis R., et al.
Publicado: (2014) -
Rosuvastatin was Effective in Acute Heart Failure and Slow Coronary Flow: A Hypothesis-generating Case Report
por: Arrivi, Alessio, et al.
Publicado: (2013)